{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:24:08Z","timestamp":1761675848104},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,5,19]],"date-time":"2011-05-19T00:00:00Z","timestamp":1305763200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s00108-010-2766-3","type":"journal-article","created":{"date-parts":[[2011,5,17]],"date-time":"2011-05-17T09:03:11Z","timestamp":1305622991000},"page":"657-670","source":"Crossref","is-referenced-by-count":3,"title":["Spondyloarthritiden"],"prefix":"10.1007","volume":"52","author":[{"given":"J.","family":"Braun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rudwaleit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Sieper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,19]]},"reference":[{"key":"2766_CR1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/03009740701774966","volume":"37","author":"Adomaviciute","year":"2008","unstructured":"Adomaviciute D, Pileckyte M, Baranauskaite A et al (2008) Prevalence survey of rheumatoid arthritis and spondyloarthropathy in Lithuania. Scand J Rheumatol 37:113\u2013119","journal-title":"Scand J Rheumatol"},{"key":"2766_CR2","unstructured":"Assessment of SpondyloArthritis international Society (2011) ASAS slide library. www.asas-group.org"},{"key":"2766_CR3","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1136\/ard.2006.066415","volume":"66","author":"Baraliakos","year":"2007","unstructured":"Baraliakos X, Listing J, Rudwaleit M et al (2007) Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes. Ann Rheum Dis 66:910\u2013915","journal-title":"Ann Rheum Dis"},{"key":"2766_CR4","doi-asserted-by":"crossref","first-page":"R104","DOI":"10.1186\/ar2496","volume":"10","author":"Baraliakos","year":"2008","unstructured":"Baraliakos X, Listing J, Rudwaleit M et al (2008) The relationship between inflammation and new bone formation in patients with ankylosing spondylitis. Arthritis Res Ther 10:R104","journal-title":"Arthritis Res Ther"},{"key":"2766_CR5","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3899\/jrheum.080871","volume":"36","author":"Baraliakos","year":"2009","unstructured":"Baraliakos X, Listing J, von der Recke A, Braun J (2009) The natural course of radiographic progression in ankylosing spondylitis: evidence for major individual variations in a large proportion of patients. J Rheumatol 36:997\u20131002","journal-title":"J Rheumatol"},{"key":"2766_CR6","doi-asserted-by":"crossref","first-page":"i97","DOI":"10.1136\/ard.2010.140541","volume":"70","author":"Braun","year":"2011","unstructured":"Braun J, Baraliakos X (2011) Imaging of axial spondyloarthritis including ankylosing spon-dylitis. Ann Rheum Dis 70 (Suppl 1):i97\u2013i103","journal-title":"Ann Rheum Dis"},{"key":"2766_CR7","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/art.22669","volume":"57","author":"Braun","year":"2007","unstructured":"Braun J, Baraliakos X, Listing J et al (2007) Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor alpha agents. Arthritis Rheum 57:639\u2013647","journal-title":"Arthritis Rheum"},{"key":"2766_CR8","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1136\/ard.2007.075879","volume":"67","author":"Braun","year":"2007","unstructured":"Braun J, Baraliakos X, Listing J et al (2007) Persistent clinical efficacy and safety of anti-TNF\u03b1 therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response. Ann Rheum Dis 67:340\u2013345","journal-title":"Ann Rheum Dis"},{"key":"2766_CR9","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1136\/ard.2010.130559","volume":"69","author":"Braun","year":"2010","unstructured":"Braun J, Inman R (2010) Clinical significance of inflammatory back pain for diagnosis and screening of patients with axial spondyloarthritis. Ann Rheum Dis 69:1264\u20131268","journal-title":"Ann Rheum Dis"},{"key":"2766_CR10","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/art.21790","volume":"54","author":"Braun","year":"2006","unstructured":"Braun J, Landewe R, Hermann KG et al (2006) Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: Results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study. Arthritis Rheum 54:1646\u20131652","journal-title":"Arthritis Rheum"},{"key":"2766_CR11","doi-asserted-by":"crossref","unstructured":"Braun J, McHugh N, Singh A et al (2007) Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50\u00a0mg once-weekly and 25\u00a0mg twice-weekly. Rheumatology (Oxford) 46:999\u20131004","DOI":"10.1093\/rheumatology\/kem069"},{"key":"2766_CR12","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/ncprheum0296","volume":"2","author":"Braun","year":"2006","unstructured":"Braun J, Sieper J (2006) Early diagnosis of spondyloarthritis. Nat Clin Pract Rheumatol 2:536\u2013545","journal-title":"Nat Clin Pract Rheumatol"},{"key":"2766_CR13","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","volume":"369","author":"Braun","year":"2007","unstructured":"Braun J, Sieper J (2007) Ankylosing spondylitis. Lancet 369:1379\u20131390","journal-title":"Lancet"},{"key":"2766_CR14","doi-asserted-by":"crossref","unstructured":"Braun J, Sieper J (2008) What is the most important outcome in ankylosing spondylitis? Rheumatology 16 ePub","DOI":"10.1093\/rheumatology\/ken357"},{"key":"2766_CR15","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1136\/ard.2006.052878","volume":"65","author":"Braun","year":"2006","unstructured":"Braun J, Zochling J, Baraliakos X et al (2006) Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early anky-losing spondylitis: a multicentre randomized controlled trial. Ann Rheum Dis 65:1147\u20131153","journal-title":"Ann Rheum Dis"},{"key":"2766_CR16","doi-asserted-by":"crossref","first-page":"i2","DOI":"10.1136\/ard.2010.146852","volume":"70","author":"Furst","year":"2011","unstructured":"Furst DE, Keystone EC, Braun J et al (2011) Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010. Ann Rheum Dis 70 (Suppl 1):i2\u2013i36","journal-title":"Ann Rheum Dis"},{"key":"2766_CR17","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1136\/ard.2004.029199","volume":"64","author":"Guillemin","year":"2005","unstructured":"Guillemin F, Saraux A, Guggenbuhl P et al (2005) Prevalence of rheumatoid arthritis in France: 2001. Ann Rheum Dis 64:1427\u20131430","journal-title":"Ann Rheum Dis"},{"key":"2766_CR18","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1002\/art.23606","volume":"58","author":"Haibel","year":"2008","unstructured":"Haibel H, Rudwaleit M, Listing J et al (2008) Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: Results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-two. Arthritis Rheum 58:1981\u20131991","journal-title":"Arthritis Rheum"},{"key":"2766_CR19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/art.23177","volume":"58","author":"Helmick","year":"2008","unstructured":"Helmick CG, Felson DT, Lawrence RC et al; National Arthritis Data Workgroup (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 58:15\u201325","journal-title":"Arthritis Rheum"},{"key":"2766_CR20","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1136\/ard.2008.096073","volume":"68","author":"Kiltz","year":"2008","unstructured":"Kiltz U, van der Heijde, Mielants H et al; PARE\/EULAR patient initiative group (2008) ASAS\/EULAR recommendations for the management of ankylosing spondylitis: the patient version. Ann Rheum Dis 68:1381\u20131386","journal-title":"Ann Rheum Dis"},{"key":"2766_CR21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0049-0172(73)90035-8","volume":"3","author":"Moll","year":"1973","unstructured":"Moll JM, Wright V (1973) Psoriatic arthritis. Semin Arthritis Rheum 3:55\u201378","journal-title":"Semin Arthritis Rheum"},{"key":"2766_CR22","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/art.24483","volume":"60","author":"Rudwaleit","year":"2009","unstructured":"Rudwaleit M, Haibel H, Baraliakos X et al (2009) The early disease stage in axial spondylo-arthritis: Results from the German spondyloarthritis inception cohort. Arthritis Rheum 60:717\u2013727","journal-title":"Arthritis Rheum"},{"key":"2766_CR23","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1136\/ard.2009.110767","volume":"68","author":"Rudwaleit","year":"2009","unstructured":"Rudwaleit M, Jurik AG, Hermann KG et al (2009) Defining active sacroiliitis on magnetic resonance Imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS\/OMERACT MRI Group. Ann Rheum Dis 68:1520\u20131527","journal-title":"Ann Rheum Dis"},{"key":"2766_CR24","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/ard.2009.108217","volume":"68","author":"Rudwaleit","year":"2009","unstructured":"Rudwaleit M, Landew\u00e9 R, van der Heijde D et al (2009) The development of Assessment of SpondyloArthritis international Society (ASAS) classification criteria for axial spondyloarthritis (part I): Classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 68:770\u2013776","journal-title":"Ann Rheum Dis"},{"key":"2766_CR25","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/art.21619","volume":"54","author":"Rudwaleit","year":"2006","unstructured":"Rudwaleit M, Metter A, Listing J et al (2006) Inflammatory back pain in ankylosing spondylitis \u2013 a reassessment of the clinical history for classification and diagnosis. Arthritis Rheum 54:569\u2013578","journal-title":"Arthritis Rheum"},{"key":"2766_CR26","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"Rudwaleit","year":"2009","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R et al (2009) The development of Assessment of SpondyloArthritis international Society (ASAS) classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68:777\u2013783","journal-title":"Ann Rheum Dis"},{"key":"2766_CR27","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/ard.2004.029207","volume":"64","author":"Saraux","year":"2005","unstructured":"Saraux A, Guillemin F, Guggenbuhl P et al (2005) Prevalence of spondyloarthropathies in France: 2001. Ann Rheum Dis 64:1431\u20131435","journal-title":"Ann Rheum Dis"},{"key":"2766_CR28","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/ard.2008.104018","volume":"68","author":"Sieper","year":"2009","unstructured":"Sieper J, Rudwaleit M, Baraliakos X et al (2009) The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68 (Suppl 2):ii1\u201344","journal-title":"Ann Rheum Dis"},{"key":"2766_CR29","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/art.22097","volume":"55","author":"van","year":"2006","unstructured":"van der Heijde D, Han C, DeVlam K et al (2006) Infliximab improves productivity and reduces workday loss in patients with ankylosing spondylitis: results from a rando\u00acmized, placebo-controlled trial. Arthritis Rheum 55:569\u2013574","journal-title":"Arthritis Rheum"},{"key":"2766_CR30","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1002\/art.23901","volume":"58","author":"van","year":"2008","unstructured":"van der Heijde D, Landew\u00e9 R, Baraliakos X et al; Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy Study Group (2008) Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum 58:3063\u20133070","journal-title":"Arthritis Rheum"},{"key":"2766_CR31","first-page":"1811","volume":"68","author":"van","year":"2008","unstructured":"van der Heijde D, Lie E, Kvien TK et al; Assessment of SpondyloArthritis international Society (ASAS) (2008) The ASDAS is a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 68:1811\u20131818","journal-title":"Ann Rheum Dis"},{"key":"2766_CR32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"van","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361\u2013368","journal-title":"Arthritis Rheum"},{"key":"2766_CR33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/ard.2007.084426","volume":"68","author":"Visvanathan","year":"2009","unstructured":"Visvanathan S, Heijde D van der, Deodhar A et al (2009) Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis. Ann Rheum Dis 68:175\u2013182","journal-title":"Ann Rheum Dis"},{"key":"2766_CR34","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/ard.2007.071605","volume":"67","author":"Visvanathan","year":"2007","unstructured":"Visvanathan S, Wagner C, Marini JC et al (2007) Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab. Ann Rheum Dis 67:511\u2013517","journal-title":"Ann Rheum Dis"},{"key":"2766_CR35","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1007\/s10067-005-0132-y","volume":"25","author":"Zochling","year":"2006","unstructured":"Zochling J, Bohl-Buhler MH, Baraliakos X et al (2006) Nonsteroidal anti-inflammatory drug use in ankylosing spondylitis-a population-based survey. Clin Rheumatol 25:794\u2013800","journal-title":"Clin Rheumatol"},{"key":"2766_CR36","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/ard.2005.041137","volume":"65","author":"Zochling","year":"2005","unstructured":"Zochling J, van der Heijde D, Burgos-Vargas R et al; \u201aASsessment in AS\u2018 international working group; European League Against Rheumatism (2005) ASAS\/EULAR recommenddations for the management of ankylosing spondylitis. Ann Rheum Dis 65:442\u2013452","journal-title":"Ann Rheum Dis"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-010-2766-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-010-2766-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-010-2766-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T20:43:42Z","timestamp":1560199422000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-010-2766-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,19]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["2766"],"URL":"https:\/\/doi.org\/10.1007\/s00108-010-2766-3","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,19]]}}}